Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Clinical trial NCT00058656 · COMPLETED

Trial details

NCT number: NCT00058656
Sponsor: Xcyte Therapies
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2003-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.